Call 855-808-4530 or email GroupSales@alm.com to receive your discount on a new subscription.
Beginning on Nov. 13, 2018, the U.S. Patent and Trademark Office (USPTO) will cease to apply the broadest reasonable interpretation (BRI) standard for newly-filed IPR, PGR, and CBM trials under the America Invents Act (AIA). Instead, the USPTO will begin “using the same claim construction standard that would be used to construe the claim in a civil action[,] … including construing the claim in accordance with the ordinary and customary meaning of such claim … and the prosecution history pertaining to the patent.” 37 C.F.R. §42.100. The new rules also state that the USPTO will consider “[a]ny prior claim construction determination concerning a term of the claim in a civil action, or a proceeding before the International Trade Commission, that is timely made of record.” 37 C.F.R. §42.100.
By Wesley Overson, Otis Littlefield, Mat Swiderski, and Stephanie Blij
Since the U.S. Supreme Court decided Mayo and Myriad, the Federal Circuit has expanded the holdings and invalidated more patents directed to biological discoveries. If the newly discovered correlations and properties of what is found in nature cannot be patented, what strategies for protection are left for companies doing biological research?
By Kyle-Beth Hilfer
Two recent circuit court cases clarified copyright infringement of photographs on the Internet. Both cases serve as cautionary tales for those who takes photographs for their websites from the Internet without investigating copyright rights.
By Scott Graham
Stanford Law School made available to the public a database of every patent lawsuit that’s been filed since 2007.
By Howard Shire and Christine Weller
Mercedes Benz USA LLC v. Bombardier